Public outcry over high prices for drugs and health care services has caught the attention of the people who decide those prices. But that doesn't mean there will be any immediate action. A new survey from investment bank Lazard found that more than half (57%) of 300 U.S. and European health care executives and investors said pricing and reimbursement was the top challenge for them right now.

Expand chart

Data: Lazard Global Healthcare Leaders Study, 2017; Note: September 9 and December 20, 2016 with 213 C-level executives and 87 investors; Chart: Andrew Witherspoon / Axios

The problem is even more acute for the drug industry, especially in light of President Trump's occasionally harsh words. About 88% of U.S. pharma executives view pricing as the top pressure. David Gluckman, the co-head of health care at Lazard, told me that survey respondents believe pricing actions will be "driven by the government, but also significantly influenced by health insurers."

Some other snippets from the survey:

The next biggest concern was the cost and quality of health care, cited by 39% of respondents. In the United States, 80% of investors and 55% of executives believe most health care payments will be based on clinical outcomes or "value" instead of volume. More than half of respondents expect an uptick in mergers and acquisitions in the next 18 months. They expect more partnerships with companies that aren't based in the health care sector, like Apple, Google and IBM.

Go deeper

Mayors plan multifront attack on census shutdown

Illustration: Sarah Grillo/Axios

A growing number of mayors are banding together to fight what they consider to be an inaccurate and abruptly curtailed 2020 census, using an arsenal of legal, legislative and congressional efforts.

Why it matters: The outcome may determine whether President Trump or Joe Biden controls the redistricting process, which governs everything from congressional representation and redistricting to funding for schools and Head Start.

Moderator Kristen Welker will not control mics during final presidential debate

President Trump and Joe Biden at the first presidential debate in September. Photo: Scott Olson via Getty Images

A producer from the Commission on Presidential Debates will manage the operation of the candidates' microphones during Thursday's final presidential debate — not the event's moderator, NBC's Kristen Welker — a source with knowledge of the event told Axios.

Our thought bubble, via Axios' Alexi McCammond: Given President Trump's accusations of partisanship against the other debates' moderators, it makes sense that Welker would want to steer clear of any such optics during her stint in the chair.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: Many U.S. deaths were avoidable — The pandemic is getting worse again.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.